Gordon receives Nierenberg Prize

Jeffrey Gordon
Jeffrey I. Gordon, MD, at WashU Medicine, has been awarded the 21st annual Nierenberg Prize for outstanding contributions to science in the public interest. He is widely considered the founder of the field of gut microbiome research.

WashU research funding exceeds $1 billion for first time

Randall Bateman, MD (right), director of the Dominantly Inherited Alzheimer Network (DIAN) and founding director of the DIAN-Trials Unit (DIAN-TU), confers with research technician Olatayo Ajenifuja. In his lab in the Jeffrey T. Fort Neuroscience Research Building, Bateman trains junior faculty, postdoctoral fellows, graduate students and undergraduates as they investigate the causes and methods of diagnosis and treatment of Alzheimer’s disease by using a wide variety of assays and techniques. (Photo: Matt Miller/Washington University School of Medicine)
For the first time, annual research funding to Washington University in St. Louis has surpassed $1 billion. That funding supports WashU researchers tackling big challenges from Alzheimer’s disease to air pollution to childhood depression. Research funding also ripples across the economy, sparking job growth, construction and local spending.

09.23.24

Student speaks with group
Images from on and around the WashU campuses.

Harrod named Fulbright Scholar

Richard Harrod
Richard Harrod, a doctoral candidate in history in Arts & Sciences, has been named a Fulbright U.S. Scholar for 2024-25. The award, granted by the U.S. Department of State and the Fulbright Program, will allow him to research the history of education in the Sultanate of Oman.